This announcement is a separate document:
瑞麗醫美：有關1) 採納經審核綜合財務報表、董事會報告及核數師報告2) 重選退任董事3) 續聘核數師之建議，4) 建議授出發行股份及購回股份之一般授權5) 建議採納新組織章程大綱及細則及2022年股東週年大會通告
RAILY AESMED: PROPOSALS FOR 1) ADOPTION OF AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND REPORTS OF DIRECTORS AND AUDITOR, 2) RE-ELECTION OF RETIRING DIRECTORS, 3) RE-APPOINTMENT OF AUDITOR, 4) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCH
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.